As global diabetes prevalence continues to rise, insulin production must scale while meeting strict GMP and sterility requirements. This case study explores how industrial insulin manufacturing is designed, from biotechnology to aseptic formulation, and how Boccard supported a major producer in reinforcing formulation capacity.

For this greenfield project, Boccard carried out the entire project with a “global contractor” approach, thus integrating civil engineering, clean rooms, as well as all production units.